CCVAX
Price
$30.17
Change
+$0.07 (+0.23%)
Updated
Jul 31 closing price
Net Assets
1.28B
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

CCVAX vs VSCIX

CCVAX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
CCVAX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCVAX is a StrongBuy and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. CCVAX (1.28B). VSCIX pays higher dividends than CCVAX: VSCIX (1.23) vs CCVAX (0.08). CCVAX was incepted earlier than VSCIX: CCVAX (22 years) vs VSCIX (29 years). CCVAX (1.20) is less costly to investors than VSCIX (0.03). CCVAX is a more actively managed with annual turnover of: 34.00 vs. VSCIX (17.00). CCVAX has a lower initial minimum investment than VSCIX: CCVAX (1000) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 22.58 vs. CCVAX (-6.05). VSCIX return over 5 years is better than : 35.13 vs. CCVAX (-10.17).
CCVAXVSCIXCCVAX / VSCIX
Total Expense Ratio1.200.034,000%
Annual Report Gross Expense Ratio1.200.034,000%
Fund Existence22 years29 years-
Gain YTD8.79914.59160%
Front Load5%N/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.28B189B1%
Annual Yield % from dividends0.081.237%
Returns for 1 year-6.0522.58-27%
Returns for 3 years-1.2043.44-3%
Returns for 5 years-10.1735.13-29%
Returns for 10 years42.19156.0727%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C